By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Octomera533K51.50%
Therapies525K50.72%
Eliminations-23K-2.22%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
U.S.1.04M100.00%